Concorde
Device Spine
PDI 10705034306087
General payments
$207,443
Research payments
$154,035
Through program year 2024, $207,443 in general payments and $154,035 in research payments were reported against Concorde (Spine).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | General | $18,873 | 18 |
| 2023 | General | $47,898 | 38 |
| 2022 | General | $72,304 | 53 |
| 2022 | Research | $154,035 | 1 |
| 2021 | General | $68,369 | 40 |
Breakdown
The top 5 of 9 recipients; each share is of general payments naming this product in 2024.
Each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.
The top 5 of 7 states; each share is of general payments naming this product in 2024 where a state was reported.
Records
149 general · 1 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.